Dear Colleague,

it is our pleasure to announce we are now organizing Melanoma and Immunotherapy Bridge 2021,
on behalf of Fondazione Melanoma Onlus.
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and
more attendees every year, the 7 edition of Immunotherapy Bridge and the 12 edition of Melanoma
Bridge will take place from December 1 to 2 and from December 2 to 4, respectively.
Due to the COVID-19 pandemic and after the great success of last year’s first web conference edition,
we are glad to announce that also for the 2021 the Bridge will be a VIRTUAL MEETING.
The live streaming will be an opportunity to increase even more the interactive atmosphere and the
international attendance and the 2021 edition of both events will be very thrilling!
The scientific program of Immunotherapy Bridge will be focused first on important issues and will also
include a Session jointly organized with SITC.
Hence, the state of the art of immunotherapy from the clinical point of view in various types of
malignances will be exhaustively discussed and the final session will be dedicated to the neoadjuvant
therapies.
The scientific program of Melanoma Bridge will host a very actual Session to the impact of the
Covid-19 on our daily practice both clinical and research.
Then two Sessions dedicated to system biology, targeted therapies development and progresses of
melanoma research. Immunotherapy and Melanoma Bridge will end with the Great Debate Session
each, in which big topics will be shown and thoroughly discussed from two different points of view.
Attendees are expected from all around the world and encouraged to submit their abstracts for poster
or oral presentation during the dedicated sessions. We’re looking forward to meeting you again
“virtually”!